相关实验视频

Updated: Sep 17, 2025

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Published on: August 10, 2020

骨关节炎的基因治疗管道:当前的创新,运营挑战和未来的方向

Valtteri Peitso¹, Karman Ng², Ron Ellis²

¹Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.

Connective tissue research

|July 4, 2025

概括

基因疗法为治疗骨关节炎 (OA) 提供了一个有希望的新途径,这是一种使人虚弱的关节疾病. 病毒和非病毒载体的创新正在推动治疗,尽管免疫反应和成本等挑战仍然存在.

科学领域:

生物医学工程生物医学工程
分子生物学分子生物学
再生医学是一种再生医学.

背景情况:

骨关节炎 (OA) 是一种广泛的关节疾病,其标志着软骨的分解,炎症和骨的变化.
目前对OA的治疗方法不能改变疾病的进展,这凸显了对新型治疗策略的需求.
基因疗法是一种有前途的方法,通过将治疗基因直接输入关节来修改OA.

研究的目的:

审查最近在治疗骨关节炎的基因疗法的进展.
探索OA基因治疗中使用的各种病毒和非病毒载体平台.
确定OA基因疗法的挑战和未来方向.

主要方法:

关于治疗骨关节炎的基因疗法的当前文献的综述.
专注于使用腺病毒,腺相关病毒 (AAV) 和简单疹病毒载体的平台.
研究非病毒方法,包括塑体DNA输送.

主要成果:

临床前和早期临床研究表明,在OA模型中,关节内转基因表达和治疗效果持续.
通过AAV传递IL-1Ra和nkx3.2,以及编码IL-10的等离子体DNA是关键策略.
基因疗法显示出调节炎症和促进状细胞存活的潜力.

结论:

基因疗法对骨关节炎的治疗具有变革性的潜力.
克服免疫障碍,载体变异性和成本等挑战对于临床翻译至关重要.
未来的研究应该专注于改进载体系统,开发组合疗法,并确保多样化的患者群体的可访问性.

关键词:

骨关节炎 (OA) 是一种腺相关病毒 (AAV)腺病毒 (Ad)基因治疗的基因疗法互白素-1受体对手 (IL-1Ra) 的使用.转基因是指转基因的人类.

更多相关视频

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

相关概念视频

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...